For our study, we made use of two human and one mouse GBM cell line with distinct alterations in the loci of TP53, MGMT, CDKN2A, PTEN, and IDH1/2 as described for primary GBM (Table 1) (51, 52). This evidence concerns the gene TP53 and glioblastoma.